The U.S. Food and Drug Administration (FDA) recently issued a safety alert warning health care facilities and providers to suspend or avoid use of Hospira’s Symbiq Infusion System. The announcement came after the FDA, the U.S. Department of Homeland Security, and the medical device manufacturer Hospira became aware of cybersecurity vulnerabilities associated with the infusion pumps.
The Hospira Symbiq Infusion System is “a computerized pump designed ...
continue reading...
